|
Patient-reported outcomes following autologous stem cell transplantation for patients with multiple myeloma. |
| |
|
Consulting or Advisory Role - Amgen; Celgene; Takeda |
Speakers' Bureau - Amgen; Celgene; Sanofi; Takeda |
|
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
David Samuel DiCapua Siegel |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda |
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Takeda |
Research Funding - Celgene (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Amgen; Celgene; Takeda |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda |
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Takeda |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |